Shugo Shiba[Author] - Search Results

Year	Number of Results
2009	1
2011	3
2012	2
2013	1
2020	1
2021	1
2024	0

1

Tumor Vascular Microenvironment of Colorectal Hepatic Metastasis and Chemotherapy Response.

Okamoto H, Shiba S, Iino H, Sudoh M, Ichikawa D. Okamoto H, et al. Among authors: shiba s. Anticancer Res. 2021 Sep;41(9):4505-4513. doi: 10.21873/anticanres.15261. Anticancer Res. 2021. PMID: 34475076

2

Lapatinib enhances herceptin-mediated antibody-dependent cellular cytotoxicity by up-regulation of cell surface HER2 expression.

Maruyama T, Mimura K, Izawa S, Inoue A, Shiba S, Watanabe M, Kawaguchi Y, Inoue M, Nogata H, Inoue S, Fujii H, Kono K. Maruyama T, et al. Among authors: shiba s. Anticancer Res. 2011 Sep;31(9):2999-3005. Anticancer Res. 2011. PMID: 21868551

3

An extremely rare combination of choledochocele and bile duct duplication escalating severe acute pancreatitis and cholangitis: A case report.

Okamoto H, Shiba S, Wakana H, Kawashima K, Fukasawa T. Okamoto H, et al. Among authors: shiba s. Int J Surg Case Rep. 2020;76:161-165. doi: 10.1016/j.ijscr.2020.09.137. Epub 2020 Sep 23. Int J Surg Case Rep. 2020. PMID: 33032048 Free PMC article.

4

Lapatinib acts on gastric cancer through both antiproliferative function and augmentation of trastuzumab-mediated antibody-dependent cellular cytotoxicity.

Shiraishi K, Mimura K, Izawa S, Inoue A, Shiba S, Maruyama T, Watanabe M, Kawaguchi Y, Inoue M, Fujii H, Kono K. Shiraishi K, et al. Among authors: shiba s. Gastric Cancer. 2013 Oct;16(4):571-80. doi: 10.1007/s10120-012-0219-5. Epub 2012 Nov 28. Gastric Cancer. 2013. PMID: 23187882

5

Expression of MHC Class I on breast cancer cells correlates inversely with HER2 expression.

Inoue M, Mimura K, Izawa S, Shiraishi K, Inoue A, Shiba S, Watanabe M, Maruyama T, Kawaguchi Y, Inoue S, Kawasaki T, Choudhury A, Katoh R, Fujii H, Kiessling R, Kono K. Inoue M, et al. Among authors: shiba s. Oncoimmunology. 2012 Oct 1;1(7):1104-1110. doi: 10.4161/onci.21056. Oncoimmunology. 2012. PMID: 23170258 Free PMC article.

6

Immunonutritional diet modulates natural killer cell activation and Th17 cell distribution in patients with gastric and esophageal cancer.

Maruyama T, Mimura K, Izawa S, Shiba S, Watanabe M, Kawaguchi Y, Fujii H, Kono K. Maruyama T, et al. Among authors: shiba s. Nutrition. 2011 Feb;27(2):146-52. doi: 10.1016/j.nut.2010.07.007. Nutrition. 2011. PMID: 21215924

7

Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytotoxicity of EGFR- and HER2-overexpressing esophageal cancer cell lines.

Mimura K, Kono K, Maruyama T, Watanabe M, Izawa S, Shiba S, Mizukami Y, Kawaguchi Y, Inoue M, Kono T, Choudhury A, Kiessling R, Fujii H. Mimura K, et al. Among authors: shiba s. Int J Cancer. 2011 Nov 15;129(10):2408-16. doi: 10.1002/ijc.25896. Epub 2011 Apr 8. Int J Cancer. 2011. PMID: 21207425 Free article.

8

Complete remission of multiple recurrent hepatocellular carcinomas by oral administration of enteric-coated tegafur/uracil in a patient with huge hepatocellular carcinoma extending to the inferior vena cava after hepatic resection: analysis of mRNA expression of fluoropyrimidine metabolism enzymes in the primary tumor.

Matsuda M, Shiba S, Asakawa M, Kono H, Fujii H. Matsuda M, et al. Among authors: shiba s. Int J Clin Oncol. 2009 Jun;14(3):245-8. doi: 10.1007/s10147-008-0820-0. Epub 2009 Jul 11. Int J Clin Oncol. 2009. PMID: 19593617

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year